About Savolitinib Savolitinib is an oral, potent, and highly selective MET TKI that has demonstrated clinical…
About Aumolertinib Aumolertinib (previously known as almonertinib) is a EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M…
About Furmonertinib Furmonertinib Mesilate acts as an anti-cancer agent. It is formulated as tablets for oral…
About Tepotinib Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
ABout Crizotinib Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer…
About Repotrectinib Repotrectinib is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is taken by mouth. Repotrectinib is…
Zerpidio (Serplulimab) sold under the brand name 汉斯状 in china. Serplulimab, a recombinant humanised anti-PD-1 monoclonal…
Trametinib is a kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers…
Dabrafenib is an anti-cancer medication used for the treatment of cancers associated with a mutated version of the…
Osimertinib is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a…
Sotorasib is an anti-cancer medication used to treat non-small-cell lung cancer (NSCLC).It targets a specific mutation,…
Sotorasib is in a class of medications called KRAS inhibitors. It works by blocking the action of…
Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that…
Capmatinib is in a class of medications called kinase inhibitors. It works by blocking the action of…
Lorlatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that…